ACNM Oral Presentations

Session Description
This course will provide an update on molecular imaging and targeted therapy for benign and malignant thyroid pathology. We will include clinical pearls and pitfalls as well as illustrative case examples. The intended audience includes all members of the healthcare team who help patients with thyroid pathology (lectures will be primarily geared to residents, fellows, and practicing clinicians).

Session Objectives

• Discuss advances in benign and malignant thyroid pathology imaging
• Discuss advances in benign and malignant thyroid pathology therapy
• Review advances through the setting of illustrative case examples

Presentations

Update on Thyroid and Cancer Therapy
TBD

Update on Benign Thyroid Disease and Therapy
Katherine Zukotynski, MD, PhD, PEng, FSNMMI, Mc Master University

NETS Imaging and Therapy
Sponsored by the ACNM
Organizer: Katherine Zukotynski, MD, PhD, PEng, FSNMMI
Moderator: Ashwin Singh Parihar, MBBS, MD

Session Description
This course will provide an update on molecular imaging and targeted therapy for neuroendocrine tumors (NETs). We will include clinical pearls and pitfalls as well as illustrative case examples. The intended audience includes all members of the healthcare team who help patients with neuroendocrine tumors (lectures will be primarily geared to residents, fellows, and practicing clinicians).

Session Objectives

• Discuss advances in neuroendocrine tumor imaging
• Discuss advances in neuroendocrine tumor therapy
• Review advances through the setting of illustrative case examples

Presentations

Imaging prior to Therapy and Tips Regarding Therapy
Carina Marie Aparici, MD, FACNM, Stanford University

Treatment Response Assessment
Lisa Bodei, MD, PhD, Memorial Sloan Kettering Cancer Center

12:15–1:15 pm PT

Moderated Poster Session/Meet the Authors – ACNM

1:15–3:15 pm PT

PSMA Imaging and Therapy
Sponsored by the ACNM
Organizer: Katherine Zukotynski, MD, PhD, PEng, FSNMMI
Moderator: Ashwin Singh Parihar, MBBS, MD

Session Description
This course will provide an update on molecular imaging and targeted therapy for prostate cancer. We will include clinical pearls and pitfalls as well as illustrative case examples. The intended audience includes all members of the healthcare team who help patients with prostate cancer (lectures will be primarily geared to residents, fellows, and practicing clinicians).

Session Objectives

• Discuss advances in prostate cancer imaging
• Discuss advances in prostate cancer therapy
• Review advances through the setting of illustrative case examples

Presentations

PSMA PET: Tips and Tricks
Steven Patrick Rowe, MD, PhD, Johns Hopkins Medicine

PSMA-RLT: How We Do It
Lilja B. Solnes, MD, MBA, Johns Hopkins Medicine

3:45–5:45 pm PT

Pediatric Imaging and Therapy
Sponsored by the ACNM
Organizer: Katherine Zukotynski, MD, PhD, PEng, FSNMMI
Moderator: Ruth Lim, MD

Session Description
This course will provide an update on molecular imaging and targeted therapy for the pediatric population. We will include clinical pearls and pitfalls as well as illustrative case examples. The intended audience includes all members of the healthcare team who help pediatric patients (lectures will be primarily geared to residents, fellows, and practicing clinicians).

Session Objectives

• Discuss advances in pediatric imaging
• Discuss advances in pediatric therapy
• Review advances through the setting of illustrative case examples

Presentations

Pediatric GI Imaging:  Will a Drink Help?
Helen R. Nadel, MD, FRCPC, FSNMMI, Lucile Packard Children’s Hospital

Pediatric GU Imaging: What you were Afraid to Ask
Ruth Lim, MD, Massachusetts General Hospital/Harvard Medical School

Nuts and Bolts of Starting a Pediatric Therapy Program
Hollie Lai, MD, CHOC Children’s Hospital

MIBG Therapy: All you Need to Know!
Frederick D. Grant, MD, Children’s Hospital of Philadelphia

ACNM International Session: Theranostic Updates from Around the World
 Sponsored by the ACNM
Organizers: Twyla B. Bartel, DO, FACNM, FSNMMI; Simindokht Dadparvar, MD, FACNM, FSNMMI
Moderators: Twyla B. Bartel, DO, FACNM, FSNMMI; Simindokht Dadparvar, MD, FACNM, FSNMMI

Session Description
This session will highlight three of the ACNM’s international partners who will provide theranostic updates from their respective countries. This year, Israel, Singapore, and South Africa will be highlighted. The session is intended for any nuclear medicine specialist to reinforce their current knowledge/practices in this area as well as learn of new potential advances in theranostics from an international perspective.

Session Objectives

• ISRAEL – To learn advantages of the multidisciplinary approach in the treatment of thyroid disease in children.
• SINGAPORE: To educate about the rationale and potentials of SSR-based theranostics beyond neuroendocrine tumors.
• SOUTH AFRICA:  To understand the opportunities, challenges, and current theranostics available in South Africa.

Presentations

Treatment of Thyroid cancer in Pediatrics
Arnon A. Schwartz, MD, MBA, Beilison Hospital, Hasharon Hospital, Rabin Medical Center, Israel

Pushing Boundaries of SSR-Based Theranostics
Sean Xuexian Yan, MD, Singapore General Hospital

A Land of inequality – Theranostics in South Africa
Lizette Louw, MD, Institution Center of Molecular Imaging and Theranostics, South Africa

Q&A

10:30 am–12:30 pm PT

Mandell-Alavi Lectureship:  Better Than a Coin Toss – The Importance of Molecular Imaging in Predicting Response to Treatment with PARP Inhibitors
Sponsored by the ACNM
Organizer: Gary Ulaner, MD, PhD, FACNM
Moderator: Gary Ulaner, MD, PhD, FACNM

Session Objectives

• Discuss what are PARP inhibitors
• Examine why PARP inhibitors are important biomarkers
• List what PARP-targeted imaging and therapy molecules are being developed

Presentations

Introduction of Speaker
Gary Ulaner, MD, PhD, FACNM

Better Than a Coin Toss – The Importance of Molecular Imaging in Predicting Response to Treatment with PARP Inhibitors
Robert H. Mach, PhD, University Hospital of Pennsylvania

Discussion

1:30–3:30 pm PT

New Radiotracers Read with Experts: 18F-FES, 64Cu-DOTATATE, 18F-DCFPyL
Sponsored by the ACNM
Organizer: Katherine Zukotynski, MD, PhD, PEng, FSNMMI
Moderator: Jagruti Shah, MD

Session Description
This session will provide an update on image acquisition and interpretation using novel radiopharmaceuticals such as 18F-FES, 64Cu-DOTATATE, and 18F-DCFPyL. We will include clinical pearls and pitfalls as well as illustrative case examples. The intended audience includes all members of the healthcare team who engage in the use of novel radiopharmaceuticals (lectures will be primarily geared to residents, fellows, and practicing clinicians).

Session Objectives

• Discuss image acquisition and interpretation using 18F-FES
• Discuss image acquisition and interpretation using 64Cu-DOTATATE
• Discuss image acquisition and interpretation using 18F-DCFPyL

Presentations

Functional imaging of Breast Cancer: Focus on18F-FES
Gary Ulaner, MD, PhD, FACNM, Hoag Family Cancer Institute

Functional imaging of NETS: Focus on 64Cu-DOTATATE
Erik Mittra, MD, PhD, Oregon Health & Science University

Functional imaging of Prostate Cancer: Focus on PSMA
Andrei H. Iagaru, MD, FACNM, Stanford University

4:00–6:00 pm PT

Implementing a PSMA-RLT Program and Interesting Cases
Sponsored by the ACNM
Organizer: Katherine Zukotynski, MD, PhD, PEng, FSNMMI
Moderator: Hossein Jadvar, MD, PhD, MPH, MBA, FACNM, FSNMMI

Session Description
This course will provide an update on how to implement a program using new radiopharmaceuticals for imaging and/or therapy. We will include clinical pearls and pitfalls as well as illustrative case examples. The intended audience includes all members of the healthcare team who are involved in the use of novel radiopharmaceuticals (lectures will be primarily geared to residents, fellows, and practicing clinicians).

Session Objectives

• Discuss issues associated with implementing a new program
• Review potential solutions to accelerate use of new radiopharmaceuticals
• Review potential case scenarios for implementing a new program

Presentations

Tips and Tricks for Implementing a PSMA-RLT program
Bital Savir-Baruch, MD, FACNM, University of Arizona Department of Medical Imaging

PSMA RLT Patient Selection
Hossein Jadvar, MD, PhD, MPH, MBA, FACNM, FSNMMI, University of Southern California

Interesting Cases
Philip M. Scherer, MD, Vanderbilt University Medical Center

Interesting Cases
Patrick M. Colletti, MD, FACNM, FSNMMI, University of Southern California